BRIDGEWAY PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: C84092 | NOTTINGHAM, NG2 2JG
Showing results 101-150 of 442
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Solifenacin | 190 | 5,956 | £227 | -60.2% ▼ |
| Zopiclone | 188 | 2,470 | £111 | -66.1% ▼ |
| Atenolol | 186 | 6,636 | £143 | -69.2% ▼ |
| Lactulose | 184 | 97.0K | £899 | -44.1% ▼ |
| Warfarin sodium | 179 | 9,486 | £312 | -62.0% ▼ |
| Clobetasol propionate | 175 | 10.2K | £826 | +28.3% ▲ |
| Nicorandil | 169 | 9,060 | £1.2K | +17.4% ▲ |
| Clonazepam | 164 | 6,715 | £1.2K | +5.3% ▲ |
| Cetirizine hydrochloride | 163 | 8,725 | £416 | -67.4% ▼ |
| Edoxaban | 162 | 4,788 | £8.0K | -76.9% ▼ |
| Felodipine | 161 | 4,592 | £737 | -72.9% ▼ |
| 159 | 15.7K | £955 | -26.5% ▼ | |
| Esomeprazole | 154 | 6,048 | £700 | -61.9% ▼ |
| Latanoprost | 153 | 1,828 | £652 | -68.5% ▼ |
| Hyoscine butylbromide | 151 | 8,104 | £606 | -35.2% ▼ |
| Diclofenac diethyl | 151 | 18.8K | £1.2K | -57.5% ▼ |
| Carbomer 940/980 | 151 | 2,540 | £476 | -0.8% vs avg |
| Linagliptin | 150 | 4,200 | £4.7K | -63.4% ▼ |
| 150 | 15.0K | £616 | +14.5% ▲ | |
| Oxycodone hydrochloride | 148 | 14.1K | £1.9K | -42.2% ▼ |
| Diltiazem hydrochloride | 140 | 6,328 | £863 | -54.4% ▼ |
| Tiotropium bromide | 137 | 3,014 | £3.4K | -54.9% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 136 | 136 | £6.0K | -18.7% ▼ |
| Biphasic isophane insulin | 135 | 760 | £3.2K | +21.0% ▲ |
| Alfacalcidol | 134 | 6,420 | £881 | +8.3% ▲ |
| Insulin aspart | 132 | 923 | £6.3K | -65.3% ▼ |
| Sodium valproate | 131 | 28.3K | £2.3K | -58.8% ▼ |
| Famotidine | 130 | 4,200 | £2.3K | -73.4% ▼ |
| Quinine sulfate | 130 | 3,892 | £523 | -55.1% ▼ |
| Digoxin | 129 | 4,028 | £323 | -65.9% ▼ |
| Fenofibrate | 128 | 3,185 | £346 | +32.3% ▲ |
| Pravastatin sodium | 128 | 3,584 | £170 | -60.6% ▼ |
| Methylphenidate hydrochloride | 128 | 6,021 | £4.1K | -50.4% ▼ |
| Biphasic insulin aspart | 127 | 930 | £5.5K | +25.1% ▲ |
| Escitalopram | 125 | 3,836 | £228 | -56.1% ▼ |
| 125 | 1,155 | £272 | -40.2% ▼ | |
| Methotrexate | 124 | 3,588 | £245 | -61.9% ▼ |
| Fluticasone/umeclidinium/vilanterol | 119 | 119 | £5.0K | -49.2% ▼ |
| Morphine sulfate | 119 | 10.8K | £435 | -81.9% ▼ |
| Travoprost | 118 | 468 | £297 | +150.4% ▲ |
| Clobetasone butyrate | 118 | 5,255 | £720 | -42.2% ▼ |
| Perindopril erbumine | 114 | 3,697 | £321 | -78.5% ▼ |
| Carbamazepine | 114 | 24.5K | £1.2K | -61.6% ▼ |
| Mesalazine (Systemic) | 113 | 9,692 | £4.3K | -52.8% ▼ |
| Tolterodine | 111 | 4,592 | £682 | -25.3% ▼ |
| Sacubitril/valsartan | 110 | 6,160 | £10.1K | -54.1% ▼ |
| Combined ethinylestradiol 30mcg | 105 | 11.4K | £598 | -62.2% ▼ |
| Fluticasone propionate (Inhalation) | 104 | 104 | £3.5K | -73.1% ▼ |
| Estradiol | 103 | 2,616 | £1.2K | -61.8% ▼ |
| Mirabegron | 103 | 3,240 | £3.0K | -74.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.